NCT00002190View on ClinicalTrials.gov

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Saquinavir

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (3)

10032

Columbia Presbyterian Med Ctr, New York

91403

Pacific Oaks Med Group / Rsch & Scientific Investigation, Sherman Oaks

94114

Davies Med Ctr / c/o HIV Institute, San Francisco

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00002190 - A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients | Biotech Hunter | Biotech Hunter